IRIS
VICECONTE, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.477
NA - Nord America 1.726
EU - Europa 1.388
SA - Sud America 250
AF - Africa 70
OC - Oceania 5
Totale 5.916
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.641
SG - Singapore 1.000
RU - Federazione Russa 668
CN - Cina 616
VN - Vietnam 401
IT - Italia 284
BR - Brasile 198
HK - Hong Kong 171
DE - Germania 109
FR - Francia 89
NL - Olanda 70
JP - Giappone 57
KR - Corea 56
GB - Regno Unito 54
IN - India 44
CA - Canada 39
BD - Bangladesh 32
FI - Finlandia 27
MX - Messico 27
PL - Polonia 21
AR - Argentina 20
ZA - Sudafrica 20
CI - Costa d'Avorio 13
ID - Indonesia 13
PH - Filippine 13
SE - Svezia 12
AT - Austria 11
IQ - Iraq 11
MA - Marocco 10
PK - Pakistan 10
EC - Ecuador 9
UA - Ucraina 9
CL - Cile 8
EG - Egitto 7
SA - Arabia Saudita 7
IE - Irlanda 6
TH - Thailandia 6
VE - Venezuela 6
ES - Italia 5
JM - Giamaica 5
TR - Turchia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CO - Colombia 4
JO - Giordania 4
KE - Kenya 4
CH - Svizzera 3
ET - Etiopia 3
LT - Lituania 3
NI - Nicaragua 3
PA - Panama 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
AU - Australia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
LB - Libano 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
DJ - Gibuti 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
PW - Palau 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
SV - El Salvador 1
Totale 5.913
Salva come PNG Salva come JPEG
Città #
Singapore 522
San Jose 320
Hefei 288
Ashburn 242
Moscow 174
Hong Kong 164
Ho Chi Minh City 134
Naples 126
Beijing 118
Los Angeles 88
Hanoi 82
Chandler 67
The Dalles 67
Santa Clara 64
New York 55
Amsterdam 52
Tokyo 51
Seoul 49
Lauterbourg 43
Dallas 33
Munich 30
São Paulo 28
Frankfurt am Main 25
Council Bluffs 20
Montreal 20
Redondo Beach 20
Orem 19
Da Nang 18
Haiphong 17
Warsaw 17
Nuremberg 16
Buffalo 15
Boston 14
Millbury 14
Seattle 14
Atlanta 13
Houston 13
Brooklyn 12
Guangzhou 12
Lawrence 12
Mexico City 12
Milan 12
Stockholm 12
Turku 12
Denver 11
Des Moines 11
London 11
Rome 11
Chicago 10
Phoenix 9
Rio de Janeiro 9
Boardman 8
Can Tho 8
Chaozhou 8
Helsinki 8
Johannesburg 8
Kochi 8
Baghdad 7
Casablanca 7
Lappeenranta 7
Querétaro 7
Biên Hòa 6
Bologna 6
Charlotte 6
Chennai 6
Dublin 6
Falkenstein 6
Fisciano 6
Hải Dương 6
Paris 6
Poplar 6
Toronto 6
Bengaluru 5
Brasília 5
City of London 5
Düsseldorf 5
Guarulhos 5
Kronberg 5
Manchester 5
Napoli 5
Ottawa 5
Porto Alegre 5
San Francisco 5
Washington 5
Wilmington 5
Amman 4
Baku 4
Bắc Ninh 4
Cairo 4
Dhaka 4
Hưng Yên 4
Marseille 4
Orlando 4
Pozzuoli 4
Richmond 4
Riyadh 4
Vienna 4
Zhengzhou 4
Afragola 3
Ankara 3
Totale 3.473
Salva come PNG Salva come JPEG
Nome #
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 173
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 169
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 166
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 158
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 153
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 150
Diabetes and COVID-19: The potential role of mTOR 149
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 148
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 146
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 142
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 141
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 140
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 137
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 135
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 135
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 135
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 131
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 131
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 131
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 129
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 129
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 129
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 128
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy 128
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 128
Prevalence of Pneumocystis jirovecii Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study) 127
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab 127
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 126
Appropriateness of antibiotic prescription for targeted therapy of infections caused by multidrug-resistant bacteria: Assessment of the most common improper uses in a tertiary hospital in Southern Italy 125
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 121
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 120
Should SARS CoV-2 infection be considered an independent risk factor for Pneumocystis jirovecii pneumonia? Emerging data after two years of pandemic from a single center experience 118
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 114
Treatment of Carbapenem-Resistant Acinetobacter baumannii in Real Life (T-ACI): A Prospective Single-Center Observational Study 113
Home parenteral nutrition in patients with intestinal failure: Possible undetected complications 112
Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis 112
Chest CT in COVID-19 patients: structured vs conventional reporting 111
Outpatient Use of Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Mild-to-Moderate Coronavirus Disease 2019 105
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience 104
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center 98
Management of hepatitis B virus (HBV) infection in multiple sclerosis patients on disease modifying therapies (DMTs) 96
Long-term oritavancin therapy for shoulder prosthetic joint infection: A case guided by therapeutic drug monitoring (TDM) 93
Salvage Therapy with Rezafungin for Candida parapsilosis Spondylodiscitis: A Case Report from Expanded Access Program 91
COVID-19, SARS and MERS: are they closely related? 85
Toxoplasma Gondii Replication During Belatacept Treatment in Kidney Transplantation: A Case Report and a Review of the Literature 84
Covid-19 R0: Magic number or conundrum? 64
Epidemiology and pathogenesis of fulminant viral hepatitis in pregnant women 63
Long-term Safety and Effectiveness of Rezafungin Treatment in Candidemia and Invasive Candidiasis: Results From an Early Access Program in Italy and Germany 61
Pneumocystis jirovecii pneumonia in COVID-19: an overlooked clinical entity—Response to “Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19” 53
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study) 33
Totale 5.997
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.030
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 0 0 0 0 1 8 3 3 0 10 38 34
2022/2023256 14 14 10 8 35 35 12 27 38 48 13 2
2023/2024275 9 40 38 22 32 48 4 27 5 4 31 15
2024/20251.587 35 24 3 20 54 97 139 92 88 191 586 258
2025/20263.725 377 407 454 459 592 159 386 213 323 235 116 4
Totale 5.997